
ShareLab members raise EUR 100m
- 17. januar 20253. februar 2025
- by Esben A. Nilssen

ShareLab members
ShareLab members raise EUR 100m
By ShareLab Team published 17 Jan 2025
At ShareLab, companies raised almost EUR 100m in 2024. Most of it is Calluna Pharma's EUR 75m Series A, reflecting the costs of entering clinical phase 2 trials. However, the vast majority of ShareLab companies are in the exploratory or preclinical phase with substantially lower capital needs.
The case was covered by Norwegian financial paper Finansavisen 16 Jan 2025. Here is a facsimile (in Norwegian) of the article:

About ShareLab
ShareLab is a lab incubator with fully equipped and serviced wet labs for startups and industrial partners, as well as a community of industry experts and biotech entrepreneurs. The laboratory is located at Oslo Science Park amid Norwegian institutions like University of Oslo, Oslo University Hospital, SINTEF, and a range of life science companies. ShareLab is non-profit and will reinvest funds in cutting edge laboratories and industrial knowhow to fuel life science.
Contact
If you would like to know more, please contact the ShareLab Team via LinkedIn.